We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Avery Dennison
AVY
$13.6B
| $15.6M | 0.07% |
90,997
-67,518
| -43% | -$11.5M |
|
352
BellRing Brands
BRBR
$1.3B
| $15.6M | 0.07% |
425,494
+135,324
| +47% | +$4.85M |
|
353
Prudential Financial
PRU
$42B
| $15.2M | 0.07% |
+172,027
| New | +$14.4M |
|
|
MAXN
354
DELISTED
Maxeon Solar Technologies
MAXN
| $15.2M | 0.07% |
5,388
+2,705
| +101% | +$7.74M |
|
355
Fluence Energy
FLNC
$2.45B
| $15.2M | 0.07% |
569,231
+138,295
| +32% | +$3.09M |
|
|
FITB
356
Fifth Third Bancorp
FITB
$52.2B
| $15.1M | 0.07% |
+577,707
| New | +$14.9M |
|
357
WillScot Mobile Mini Holdings
WSC
$4.09B
| $15.1M | 0.07% |
316,671
-283,629
| -47% | -$12.7M |
|
358
Gilead Sciences
GILD
$168B
| $15.1M | 0.07% |
196,249
-5,334
| -3% | -$425K |
|
359
Valmont Industries
VMI
$9.6B
| $15.1M | 0.07% |
51,773
+44,922
| +656% | +$13M |
|
360
Hims & Hers Health
HIMS
$6.92B
| $15M | 0.07% |
1,599,324
+385,501
| +32% | +$3.82M |
|
|
GTM
361
ZoomInfo Technologies
GTM
$1.11B
| $15M | 0.07% |
591,964
-219,642
| -27% | -$5.2M |
|
362
Valaris
VAL
$5.95B
| $15M | 0.07% |
238,718
+77,955
| +48% | +$4.7M |
|
|
WBA
363
DELISTED
Walgreens Boots Alliance
WBA
| $15M | 0.07% |
526,208
-599,498
| -53% | -$19.5M |
|
364
e.l.f. Beauty
ELF
$5.51B
| $14.9M | 0.07% |
130,728
-109,941
| -46% | -$10.6M |
|
365
Copart
CPRT
$26.7B
| $14.9M | 0.07% |
+326,824
| New | +$13.5M |
|
366
Toast
TOST
$19.5B
| $14.9M | 0.07% |
658,257
-652,269
| -50% | -$13M |
|
367
Conagra Brands
CAG
$7.05B
| $14.8M | 0.07% |
437,733
+301,532
| +221% | +$10.9M |
|
368
XPeng
XPEV
$11.3B
| $14.7M | 0.07% |
1,093,313
+996,158
| +1,025% | +$9.81M |
|
|
MRTX
369
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $14.7M | 0.07% |
406,035
-272,623
| -40% | -$11.2M |
|
370
Kanzhun
BZ
$7.12B
| $14.6M | 0.07% |
970,885
+859,097
| +769% | +$14.4M |
|
371
Tencent Music
TME
$13.8B
| $14.6M | 0.07% |
1,974,086
+644,281
| +48% | +$4.87M |
|
372
Thermo Fisher Scientific
TMO
$222B
| $14.5M | 0.07% |
+27,851
| New | +$15M |
|
373
Coca-Cola Europacific Partners
CCEP
$47.4B
| $14.5M | 0.07% |
225,023
-174,595
| -44% | -$11.1M |
|
374
Entergy
ETR
$50.2B
| $14.3M | 0.07% |
292,998
+138,220
| +89% | +$7.16M |
|
375
Alnylam Pharmaceuticals
ALNY
$29.6B
| $14.2M | 0.07% |
74,858
-66,530
| -47% | -$13.2M |
|
Similar funds
CS
VAI
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.